Effect and mechanism of allergen-specific immunotherapy on small airway dysfunction in children with asthma

被引:0
|
作者
Zhong, Wenwei [1 ]
Ying, Xiaolan [2 ]
Zhang, Lei [2 ]
Dong, Wenfang [2 ]
Lin, Jie [2 ]
Yang, Lin [3 ]
Hong, Li [3 ,4 ]
Yin, Yong [2 ]
Wu, Jinhong [2 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Pediat, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Resp Med, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Clin Nutr, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Lab Dept, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
allergen-specific immunotherapy; asthma; basophil; child; small airway dysfunction; SUBCUTANEOUS IMMUNOTHERAPY; EFFICACY; SAFETY;
D O I
10.1002/ppul.27341
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The purpose of this study was to investigate the effectiveness of allergen-specific immunotherapy (AIT) on small airway dysfunction (SAD) and the underlying mechanism with a special focus on basophils. Methods: Sixty-five children with mild to moderate asthma who were under regular inhaled corticosteroid (ICS) treatment for more than 1 year but whose FEF75 remained below 65% of the predicted value and had positive results for serum Der p or Der f were enrolled. Children with asthma underwent house dust mite (HDM) subcutaneous immunotherapy (SCIT) treatment for 1 year. Clinical symptoms and lung function were evaluated every 3 months during HDM SCIT treatment. Basophil activation test (BAT) was carried out before and after HDM SCIT treatment. RNA sequencing was performed in isolated basophils from peripheral blood after 6 months of HDM SCIT treatment, followed by GO term and KEGG pathway enrichment analysis between patients with and without HDM SCIT treatment. Results: HDM AIT treatment ameliorated clinical symptoms while concurrently improved lung function parameters, such as FEV1/FVC, FEF75, FEF50 and MMEF (p < .05). It is worth noting that FEF75 values showed a highly significant, gradual and persistent increase (from 49.55 +/- 1.27% at baseline to 71.89 +/- 2.64% after 1 year of therapy) and 22 of 35 patients no longer had SAD after 1 year of treatment. BAT results revealed that AIT treatment significantly reduced basophil activity to the inhalant allergen mixtures containing HDM in vitro challenge from baseline. GO term and KEGG pathway enrichment analysis of basophils revealed that downregulated genes were mainly involved in immune cell activation, antigen presentation, and Th2 cell differentiation. Conclusions: Our study demonstrated that HDM AIT not only improved SAD related lung function parameters, but also reduced basophil activity. RNA sequencing revealed the inhibition of phagocytosis and the phagosome pathway in basophils which may affect the polarization of Th2 cell differentiation after HDM AIT.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Allergen-specific immunotherapy
    Moote, William
    Kim, Harold
    Ellis, Anne K.
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2018, 14
  • [22] Allergen-specific immunotherapy
    William Moote
    Harold Kim
    Allergy, Asthma & Clinical Immunology, 7 (Suppl 1)
  • [23] Cockroach allergy and allergen-specific immunotherapy in asthma: potential and pitfalls
    Bassirpour, Gillian
    Zoratti, Edward
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 14 (06) : 535 - 541
  • [24] Allergen-Specific Immunotherapy in the Treatment of Pediatric Asthma: A Systematic Review
    Rice, Jessica L.
    Diette, Gregory B.
    Suarez-Cuervo, Catalina
    Brigham, Emily P.
    Lin, Sandra Y.
    Ramanathan, Murugappan, Jr.
    Robinson, Karen A.
    Azar, Antoine
    PEDIATRICS, 2018, 141 (05)
  • [25] DermAll allergen-specific immunotherapy: a new nanomedicine-based allergen-specific immunotherapy
    Garaczi, E.
    Szabo, K.
    Csiszovszki, Z.
    Loerincz, O.
    Kemeny, L.
    Lisziewicz, J.
    ALLERGY, 2013, 68 : 118 - 118
  • [26] Allergen-Specific Immunotherapy for Pediatric Asthma and Rhinoconjunctivitis: A Systematic Review
    Kim, Julia M.
    Lin, Sandra Y.
    Suarez-Cuervo, Catalina
    Chelladurai, Yohalakshmi
    Ramanathan, Murugappan
    Segal, Jodi B.
    Erekosima, Nkiruka
    PEDIATRICS, 2013, 131 (06) : 1155 - 1167
  • [27] The effect of allergen-specific immunotherapy on the quality of life of school-age children with asthma and sensitization to cat allergens
    Kryvopustova, M.
    Volosovets, O.
    Serrhii, Y.
    ALLERGY, 2023, 78
  • [28] Adjuvants in allergen-specific immunotherapy
    Klimek, L.
    Kramer, M.
    Pfaar, O.
    ALLERGOLOGIE, 2017, 40 (02) : 46 - 49
  • [29] Allergen-specific immunotherapy to mosquitoes
    Beaudouin, E
    Kanny, G
    Renaudin, JM
    Moneret-Vautrin, DA
    ALLERGY, 2001, 56 (08) : 787 - 787
  • [30] Mechanisms of allergen-specific immunotherapy
    Globinska, Anna
    Boonpiyathad, Tadech
    Satitsuksanoa, Pattraporn
    Kleuskens, Mirelle
    van de Veen, Willem
    Sokolowska, Milena
    Akdis, Mubeccel
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (03) : 306 - 312